Zobrazeno 1 - 10
of 2 979
pro vyhledávání: '"hematological malignancy"'
Autor:
Weilin Wang, Xueju Xu, Songting Bai, Lu Wang, Jixia Luo, Daiyan Zhao, Ping Li, Qiuxia Fan, Chunmei Wang, Qianghua Yao, Bai Li, Dao Wang
Publikováno v:
Pediatrics and Neonatology, Vol 65, Iss 6, Pp 553-559 (2024)
Background: Data on SARSCoV-2 infection in children with hematological malignancies (HM) are limited. Here, we describe the clinical features of children with HM after SARS-CoV-2 infection and investigate the potential risk factors for disease severi
Externí odkaz:
https://doaj.org/article/a2c941b444d94828a465376ab08a9382
Autor:
Mohammad-Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Mahsa Akbarzadeh
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-19 (2024)
Abstract Leukemia remains a major therapeutic challenge in clinical oncology. Despite significant advancements in treatment modalities, leukemia remains a significant cause of morbidity and mortality worldwide, as the current conventional therapies a
Externí odkaz:
https://doaj.org/article/c2093e559cf94965849f097ebaab2637
Autor:
Cheng Zu, Wenxiao Li, Mingming Zhang, Yetian Dong, Shan Fu, Jingjing Feng, Ruimin Hong, He Huang, Yongxian Hu, Junwei Su
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Pneumocystis jirovecii pneumonia (PcP) is an opportunistic infection associated with immunocompromised patients. The development of novel immunotherapies has promoted the incidence of PcP. This study describes the clinical course
Externí odkaz:
https://doaj.org/article/396fe88399fc45c3b8ef0286d5d0d7d3
Autor:
Shafieeh Mansoori, Ahmad Noei, Amirhosein Maali, Seyedeh Sheila Seyed-Motahari, Zahra Sharifzadeh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-22 (2024)
Abstract CAR-T cell therapy is known as an effective therapy in patients with hematological malignancies. Since 2017, several autologous CAR-T cell (auto-CAR-T) drugs have been approved by the US Food and Drug Administration (FDA) for the treatment o
Externí odkaz:
https://doaj.org/article/8699bf73261d447d9122bc152fd6efde
Autor:
Ocung Guido, Margaret Lubwama, Prossy Kiconco, Alfred Okeng, Irene Najjingo, Emmanuel Aboce, Rembo Phiona, Hanifah Nabbanja, Mariam Ndagire, Kamala Eva, Wekiya Enock, Jackson Orem, Moses L. Joloba, Freddie Bwanga
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT Hematological cancers, including Leukemias and Lymphomas, and their associated chemotherapy and disease-specific factors, are linked to impaired granulocyte function and numbers, increasing the risk of opportunistic infections, often present
Externí odkaz:
https://doaj.org/article/cd9615c6c163491fa6179e09f483e52f
Autor:
Qianqian Zhang, Jinying Zhao, Yating Liu, Yan Cui, Wen Wang, Junjie Li, Yanxia Liu, Fei Tian, Zhixin Wang, Huijuan Zhang, Guiying Liu, Yun Wu, Qiuhuan Li, Tingyu Hu, Wen Zhang, Wenjun Xie
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The Patient-Reported Outcomes Measurement Information System 29-item Profile version 2.1 (PROMIS-29 V2.1) is a widely utilized self-reported instrument for assessing health outcomes from the patients’ perspectives. This study aimed to eval
Externí odkaz:
https://doaj.org/article/832139bc392042aa923d6fdf2c3af372
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTBackground Immune checkpoints are receptors on the surface of T cells that function crucially in suppressing the immune response, and they are implicated in autoimmunity and cancer diseases.Aim The present study aimed to investigate the relat
Externí odkaz:
https://doaj.org/article/3b5170d4663d4d33bdaa0805795db7e2
Publikováno v:
Biomolecules & Biomedicine (2024)
Invasive pulmonary aspergillosis (IPA) is the most frequent invasive fungal disease occurring in patients with hematological malignancies. Serum galactomannan (GM) antigen monitoring is thought to be helpful in the diagnosis of IPA. The aim of this s
Externí odkaz:
https://doaj.org/article/1e9c18ffa7f1419c96ddae26d257b12e
Autor:
Yin Lu, Tao You, Qin Ma, Weijuan Wang, Jiaqian Qi, Pan Yang, Yaya Song, Jia Chen, Jianhong Fu, Yongqin Ge, Xiaming Zhu, Depei Wu
Publikováno v:
Cancer Medicine, Vol 13, Iss 13, Pp n/a-n/a (2024)
Abstract Aim This study aimed to explore the association between patient‐reported items at different time points after hematopoietic stem cell transplantation (HSCT) and long‐term survival. Methods We conducted a study with 144 allogeneic HSCT pa
Externí odkaz:
https://doaj.org/article/4d430ab15e66417aa105368176d0dd7c
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Hematopoietic stem cell transplantation (HSCT) is a widely used treatment for malignant hematological diseases; however, some patients inevitably experience relapse. Therefore, for patients who relapse after the first HSCT (HSCT1), a standard treatme
Externí odkaz:
https://doaj.org/article/d678a2dd682b404f9333540d4dbc5872